Antipodes Partners LTD 908 Devices Inc. Transaction History
Antipodes Partners LTD
- $4.06 Billion
- Q3 2025
A detailed history of Antipodes Partners LTD transactions in 908 Devices Inc. stock. As of the latest transaction made, Antipodes Partners LTD holds 5,227 shares of MASS stock, worth $28,643. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,227
Previous 6,558
20.3%
Holding current value
$28,643
Previous $46,000
2.17%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MASS
# of Institutions
112Shares Held
24.7MCall Options Held
39.9KPut Options Held
13.6K-
Awm Investment Company, Inc. New York, NY5.2MShares$28.5 Million5.64% of portfolio
-
First Light Asset Management, LLC Edina, MN2.51MShares$13.8 Million2.64% of portfolio
-
State Street Corp Boston, MA2.3MShares$12.6 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.95MShares$10.7 Million0.12% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$9.28 Million0.0% of portfolio
About 908 Devices Inc.
- Ticker MASS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,590,200
- Market Cap $173M
- Description
- 908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...